SARS‐CoV‐2 vaccine‐related adverse events in Zimbabwe: the need to strengthen pharmacovigilance in resource‐limited settings

Corresponding Author

ICAP at Columbia University, Harare, Zimbabwe

School of Health Systems & Public Health, University of Pretoria, Pretoria, South Africa

Correspondence

Dr Tafadzwa Dzinamarira; School of Health Systems & Public Health, University of Pretoria, Pretoria, 0002, South Africa;

View original article

0 0 0 0 0 0 0

留言 (0)